ArticleJPGN reports2025
A Canadian multicenter pediatric eosinophilic esophagitis cohort: Evidence for a nondilation approach to esophageal narrowing.
Article in JPGN reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Recommendations for the diagnosis and management of eosinophilic esophagitis in adults and children in Canada: a Delphi consensus project.Journal of the Canadian Association of Gastroenterology · 2025Review
- Recommendations for the diagnosis and management of eosinophilic esophagitis in adults and children in Canada: a Delphi consensus project.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2025Review
- A Canadian multicenter pediatric eosinophilic esophagitis cohort: Evidence for a nondilation approach to esophageal narrowing.JPGN reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Improving characterization of the narrowing phenotype in pediatric eosinophilic esophagitis (EoE). Methods: New pediatric EoE diagnoses from 2015 to 2018 were retrospectively identified in Vancouver (BC), Northern Alberta (AB), Hamilton (ON), and Nova Scotia (NS). Incidence rates were calculated using 2016 Federal census data. Clinical, endoscopic, and histologic data were gathered from diagnosis until the end of the follow-up period (fall 2019). Results: The incidence of EoE in patients less than 15 years old was 5.4 per 100,000 person-years. Of the 332 new diagnoses, 40 (12.0%) had endoscopically identified esophageal narrowing at diagnosis or during the follow-up period, with a subset of 11 (27.5% of narrowed cohort) patients undergoing mechanical esophageal dilation. The median age at diagnosis and median duration of symptoms were higher in the cohort with narrowing than those without. Patient-reported food bolus impaction and dysphagia were associated with esophageal narrowing. Trachealization was the endoscopic finding most commonly associated with esophageal narrowing. Of the 65 esophagogastroduodenoscopies performed in the follow-up of a known esophageal narrowing, 4 of the 31 (13%) had resolution of this finding post mechanical dilation, and 19 of the 39 (49%) had resolution of the narrowing after initiation of new medical or dietary treatments (without dilation). Conclusions: EoE is common in Canadian children, with esophageal narrowing being present within a few years of diagnosis in 12% of cases. Interestingly, a large portion of narrowing resolved
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.